| mRNA |
LY-2157299 |
CTRPv2 |
pan-cancer |
AAC |
-0.0087 |
0.9 |
| mRNA |
Carboplatin |
CTRPv2 |
pan-cancer |
AAC |
0.004 |
0.9 |
| mRNA |
Axitinib |
FIMM |
pan-cancer |
AAC |
0.021 |
0.9 |
| mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0057 |
0.9 |
| mRNA |
WH-4-023 |
GDSC1000 |
pan-cancer |
AAC |
-0.0061 |
0.9 |
| mRNA |
lenalidomide |
FIMM |
pan-cancer |
AAC |
0.021 |
0.9 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0033 |
0.9 |
| mRNA |
ML334 diastereomer |
CTRPv2 |
pan-cancer |
AAC |
0.0046 |
0.9 |
| mRNA |
Curcumin |
CTRPv2 |
pan-cancer |
AAC |
-0.0035 |
0.9 |
| mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.003 |
0.9 |